Though biologic medications have improved the treatment landscape by providing the solution to many unmet medical needs, biologics cost much more than small-molecule chemical medications. Biosimilars ...

The designation means that pharmacists can switch patients to the less-expensive version of insulin without seeking approval from the clinician. The FDA late Thursday approved the country’s first ...

An interchangeable product can be expected to produce the same clinical result as the reference product in any given patient. Yesafili and Opuviz are both vascular endothelial growth factor (VEGF) ...

Please provide your email address to receive an email when new articles are posted on . Simlandi is the first interchangeable, citrate-free Humira biosimilar available in a high concentration. The ...

The approval was based on a comprehensive review of scientific evidence that showed the 2 products were highly similar with no clinically meaningful differences. An interchangeable product is a ...

The Food and Drug Administration’s decision on Wednesday to approve a long-acting insulin called Semglee (insulin glargine-yfgn) as the first interchangeable biologic licensed for the U.S. market ...